Logistics & Distribution Segment by Product Is Expected to Grow at a Fast Pace over the Forecast Period.
According to a new market research study of ‘Clinical Trial Supplies Market to 2027 - Global Analysis and Forecasts by Product & Service, Stage, Drug Type, and Application.’ The global clinical trial supplies market is expected to reach US$ 3,298.91 Mn in 2027 from US$ 1,867.44 Mn in 2019. The market is estimated to grow with a CAGR of 7.4% from 2020-2027. The report provides trends prevailing in the global clinical trial supplies market and the factors driving market along with those that act as hindrances.
The global clinical trial supplies market, based on the product & service, is segmented into logistics & distribution, manufacturing, and packaging & labelling. The logistics & distribution segment held the largest share of the market in 2019. The same segment is estimated to register the highest CAGR in the market during the forecast period as the increasing adoption of this method due to the extended range of advantages. Moreover, the globalization of clinical trials and the growing number of clinical trials involving temperature-sensitive products are anticipated to drive the growth of the segment during the forecast period.
The clinical trial supplies market is anticipated to increase, owing to factors such as increasing pharmaceutical and biopharmaceutical R&D expenditures and an increase in the number of clinical trials. Moreover, growing opportunities in developing nations are likely to have a positive impact on the growth of the market in the coming years.
Leading companies operating in the clinical trial supplies market are Catalent, Inc., Thermo Fisher Scientific, Inc. Almac Group, Parexel International Corporation, Biocair, UDG Healthcare plc (Sharp), PCI Healthcare Services, Owens & Minor Inc., KLIFO, Rubicon Research Pvt. Ltd., among others. These companies have been executing different approaches that have helped the growth of the company and, in turn, have brought about various changes in the market. The companies have utilized strategies such as acquisition, collaboration, and partnerships for the growth of their organizations. For instance, in February 2020, PCI Pharma Services acquired Bellwyck Pharma Services as part of its global expansion in Clinical Trial Services in Canada and the Continental European region.
The report segments global clinical trial supplies market as follows:
Global Clinical Trial Supplies Market - By Product & Service
Global Clinical Trial Supplies Market - By Stage
Global Clinical Trial Supplies Market - By Drug Type
Global Clinical Trial Supplies Market - By Application
Global Clinical Trial Supplies Market - By Geography
North America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)
South & Central America (SCAM)
Reasons to Buy
According to a new market research study of ‘Clinical Trial Supplies Market to 2027 - Global Analysis and Forecasts by Product & Service, Stage, Drug Type, and Application.’ The global clinical trial supplies market is expected to reach US$ 3,298.91 Mn in 2027 from US$ 1,867.44 Mn in 2019. The market is estimated to grow with a CAGR of 7.4% from 2020-2027. The report provides trends prevailing in the global clinical trial supplies market and the factors driving market along with those that act as hindrances.
The global clinical trial supplies market, based on the product & service, is segmented into logistics & distribution, manufacturing, and packaging & labelling. The logistics & distribution segment held the largest share of the market in 2019. The same segment is estimated to register the highest CAGR in the market during the forecast period as the increasing adoption of this method due to the extended range of advantages. Moreover, the globalization of clinical trials and the growing number of clinical trials involving temperature-sensitive products are anticipated to drive the growth of the segment during the forecast period.
The clinical trial supplies market is anticipated to increase, owing to factors such as increasing pharmaceutical and biopharmaceutical R&D expenditures and an increase in the number of clinical trials. Moreover, growing opportunities in developing nations are likely to have a positive impact on the growth of the market in the coming years.
Leading companies operating in the clinical trial supplies market are Catalent, Inc., Thermo Fisher Scientific, Inc. Almac Group, Parexel International Corporation, Biocair, UDG Healthcare plc (Sharp), PCI Healthcare Services, Owens & Minor Inc., KLIFO, Rubicon Research Pvt. Ltd., among others. These companies have been executing different approaches that have helped the growth of the company and, in turn, have brought about various changes in the market. The companies have utilized strategies such as acquisition, collaboration, and partnerships for the growth of their organizations. For instance, in February 2020, PCI Pharma Services acquired Bellwyck Pharma Services as part of its global expansion in Clinical Trial Services in Canada and the Continental European region.
The report segments global clinical trial supplies market as follows:
Global Clinical Trial Supplies Market - By Product & Service
- Logistics & Distribution
- Manufacturing
- Packaging & Labelling
Global Clinical Trial Supplies Market - By Stage
- Phase III
- Phase II
- Bioequivalence Studies
- Phase I
Global Clinical Trial Supplies Market - By Drug Type
- Small-molecule Drugs
- Biologic Drugs
Global Clinical Trial Supplies Market - By Application
- Oncology
- Cardiovascular Diseases
- Neurological Disorders
- Respiratory Disorders
- Others
Global Clinical Trial Supplies Market - By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- U.K
- Spain
- Italy
Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
Middle East & Africa (MEA)
- Saudi Arabia
- U.A.E
- South Africa
South & Central America (SCAM)
- Brazil
- Argentina
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the clinical trial supplies market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global clinical trial supplies market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Clinical Trial Supplies - Market Landscape
5. Clinical Trial Supplies - Key Market Dynamics
6. Clinical Trial Supplies Market - Global Analysis
7. Clinical Trial Supplies Market Analysis - By Product and Service
8. Clinical Trial Supplies Market - By Stage
9. Clinical Trial Supplies Market - By Drug Type
10. Clinical Trial Supplies Market - By Application
11. Clinical Trial Supplies Market - Geographic Analysis
12. Impact Of COVID-19 Pandemic On Global Clinical Trial Supplies Market
13. Clinical Trial Supplies Market - Industry Landscape
14. Clinical Trial Supplies Market - Key Company Profiles
15. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Catalent, Inc.
- Thermo Fisher Scientific, Inc.
- Almac Group
- Parexel International Corporation
- Biocair
- UDG Healthcare plc (Sharp)
- PCI Healthcare Services
- Owens & Minor Inc.
- KLIFO
- Rubicon Research Pvt. Ltd.
